| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.06B | +0.1% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.00B | -374.1% |
| Gross margin | 22.6% | Net margin -7.2% |
| Revenue Q/Q | -67.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.05B | 77.4% |
| R&D | ¥0.01B | 9.6% |
| SG&A | ¥0.02B | 29.6% |
| Tax & other | ¥-0.00B | -1.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
卡莱特 ・ 汇成真空 ・ 昊帆生物 ・ 仁信新材 ・ 宏景科技 ・ 溯联股份 ・ 星源卓镁 ・ 英特科技 ・ 华人健康 ・ 安培龙 ・ 协昌科技 ・ 阿莱德
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies